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Introduction: Depressive disorders are a common illness worldwide. Major depres-
sion	 is	 known	as	 a	 significant	predictor	of	 the	metabolic	 syndrome.	However,	 the	
effects of depression on adipose tissue compartments are controversial. This meta-
analysis aimed to evaluate the state of research on the relationship between patients 
with depression and adipose tissue compartments as compared to nondepressed 
individuals.
Methods: The PubMed database was searched for human studies that measured 
adipose	 tissue	 compartments	 such	 as	 visceral	 adipose	 tissue	 (VAT),	 subcutaneous	
adipose	tissue	(SAT)	and/or	organ-specific	adipose	tissue	measurements	using	dual-
energy	X-ray	absorptiometry,	magnetic	resonance	imaging	or	computed	tomography	
scan and reported the means and a measure of variance separately for depressed 
individuals	and	healthy	controls.	Twelve	articles	were	identified,	including	a	total	of	
1,141	depressed	and	2,545	nondepressed	individuals.
Results: Major depressive disorder and self-reported depressive symptoms were as-
sociated with elevated visceral adipose tissue and elevated subcutaneous adipose 
tissue.	 Subanalyses	 for	 gender,	 age,	 method	 of	 adipose	 tissue	measurement,	 and	
method of depression assessment showed elevated visceral adipose in depressed 
individuals. The results could be replicated when focussing on studies controlling for 
body	mass	index	(BMI).	Regarding	other	adipose	tissue	compartments,	meta-analysis	
could not be carried out due to lack of studies.
Conclusions: Depression is associated with enlarged visceral and subcutaneous adi-
pose	tissue.	Further,	especially	longitudinal,	research	is	needed	to	identify	the	mech-
anism through which depressive disorders contribute to visceral adiposity.
K E Y W O R D S
depression,	intra-abdominal	fat,	major	depressive	disorder,	metabolic	syndrome,	
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1  | INTRODUC TION
Depressive disorders are the third leading cause of years lived with 
disability	 in	 both	 sexes	 combined	 (GBD	 2017	 Disease	 and	 Injury	
Incidence	 and	 Prevalence	 Collaborators,	 2018).	 Depressive	 symp-
toms	 include	 depressed	 mood,	 diminished	 interest	 or	 pleasure,	
changes	 in	 appetite	 and/or	 weight,	 sleep	 disorders,	 psychomotor	
alteration,	fatigue,	feelings	of	worthlessness	or	guilt,	concentration	
problems,	and	recurrent	thoughts	of	death	with	or	without	a	specific	
plan for committing suicide. For a diagnosis of a major depressive 
disorder five or more of these symptoms have to be present during 
the same 2-week-period and have to cause clinically significant dis-
tress	(American	Psychiatric	Association,	2013).
Depressed patients have an increased risk of being or becoming 
obese,	and	obese	patients	have	a	higher	risk	of	being	or	becoming	
depressed—the association between depression and obesity is bidi-
rectional	(Mannan	et	al.,	2016).	In	this	regard,	abdominal	obesity	is	
of special interest because it is the most prevalent manifestation of 
metabolic	syndrome	(Despres	&	Lemieux,	2006).	Other	manifesta-
tions	of	metabolic	syndrome	are	atherogenic	dyslipidaemia,	elevated	
blood	 pressure,	 insulin	 resistance,	 a	 proinflammatory	 state,	 and	 a	
prothrombotic	 state	 (Sperling	et	al.,	2015).	Abdominal	obesity	 is	a	
marker	of	“dysfunctional	adipose	tissue”	(Despres	&	Lemieux,	2006).	
The accumulation of harmful ectopic fat is associated with cardio-





prevalence	 of	metabolic	 syndrome	 (Goldbacher	 et	 al.,	 2009).	 This	
association is stronger with higher severity of depressive symptoms 
(Crichton	et	al.,	2016;	Hiles	et	al.,	2016).	Depressed	patients	have	an	
increased	 risk	of	having	or	getting	a	metabolic	 syndrome,	and	pa-
tients with a metabolic syndrome have an increased risk of being or 
becoming depressed—the association between depression and met-
abolic	syndrome	is	bidirectional	(Pan	et	al.,	2012).
There is some evidence that patients with severe mental ill-
ness	 display	 increased	 amounts	 of	 visceral	 adipose	 tissue	 (VAT).	
Frequently,	adipose	tissue	 is	divided	 into	the	following	subcatego-
ries:	subcutaneous	adipose	tissue	(SAT)	and	VAT	(Kahl	et	al.,	2018).	

















radiation exposure and because of the labor-intensity of postpro-




tionless	 for	 the	 relatively	 long	 scan	 time,	 and	 requires	 specialized	




of this possible pathway is important given the clinical relevance of 
both	depression	and	metabolic	syndrome.	Therefore,	we	performed	
a meta-analysis of studies comparing adipose tissue compartments 




This meta-analysis followed the Preferred Reporting Items for 
Systematic	 Reviews	 and	 Meta-Analyses	 (PRISMA)	 statement,	
Figure	1	provides	the	flowchart	 (Moher	et	al.,	2015).	Studies	were	
identified through a comprehensive literature search of the com-
puterized	PubMed	database	from	its	inception	to	August	24,	2018	
without language restrictions and with the search terms adipose 
tissue and mental disorders. The results were restricted to human 
studies. We first screened each title and abstract of the articles to 
exclude irrelevant publications and then reviewed the full texts of 
the	remaining	articles.	The	inclusion	criteria	were	as	follows:	(1)	as-
sessment of adipose tissue compartments such as visceral adipose 
tissue	(VAT)	and/or	subcutaneous	adipose	tissue	(SAT)	and/or	organ-
specific	adipose	tissue,	(2)	comparison	of	at	 least	one	fat	compart-





tion or standard error of the different fat compartments.
2.2 | Data extraction
Data	were	extracted	using	standardized	data	abstraction	forms	(see	
Table	 1).	 The	 extracted	 information	 included	 the	 authors’	 names,	
year	of	publication,	country	where	the	study	was	conducted,	sam-
ple	 size,	 sex	 and	mean	age	of	 the	participants,	 depression	 assess-
ment	method,	 use	 of	 antidepressants,	 fat	 compartment	measured	






(Cohen,	 1988)	 was	 calculated	 according	 to	 Lenhard	 and	 Lenhard	







the consistency of effects across studies with the Q and I2 statistics. 
With regard to I2,	hetereogeneity	can	be	interpreted	as	 low	(25%),	
moderate	(50%)	or	high	(75%)	(Higgins	et	al.,	2003).	Due	to	moderate	
to high heterogeneity within our studies reporting visceral adipose 
F I G U R E  1  Flow	of	information	according	to	the	PRISMA	statement
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tissue we conducted random effect models for calculation of visceral 
adipose	tissue,	whereas	studies	reporting	subcutaneous	adipose	tis-
sue showed low to moderate heterogeneity so that we conducted 
fixed effect models for calculation of subcutaneous adipose tissue 
(Ades	et	al.,	2005;	Fleiss,	&	Gross,	1991).
To	 determine	 the	 validity	 of	 the	 meta-analyses,	 we	 employed	
funnel	 plots	 (i.e.,	 plots	 of	 the	 standard	 difference	 in	 means	 [d] 
against the SEM).	 This	 was	 followed	 by	 a	 quantitative	 evaluation	
of	the	degree	of	asymmetry	(Borenstein	et	al.,	2013).	The	analyses	
were independently performed for visceral adipose tissue and sub-
cutaneous	adipose	tissue	(see	Figures	2	and	3).	We	then	calculated	
moderator analyses for visceral adipose tissue with method of de-
pression	assessment	 (screening	vs.	diagnosis),	mean	age	of	partici-
pants	(median-split	of	studies	according	to	mean	age	of	participants),	
measurement	method	of	 adipose	 tissue	 (CT	 vs.	DXA	versus.	MRI)	
and	gender	(female	vs.	male)	as	possible	moderators.
To	 facilitate	 interpretation	 of	 nonsignificant	 results,	 we	 per-
formed	post-hoc	power	analyses	according	to	Valentine	et	al.	(2010)	




Visceral adipose tissue was significantly larger in depressed sub-
jects	than	in	healthy	controls	(SMD	=	0.35,	95%	CI	=	[0.13;	0.57],	
p =	 .002)	 (see	 Figure	 4).	 Post-hoc	 statistical	 power	was	 99.95%.	
In	two	of	the	 included	studies	 (Krishnamurthy	et	al.,	2008;	Xiong	
et	al.,	2017),	BMI	was	significantly	greater	in	the	depression	group	
than	 in	 the	 control	 group.	 As	 BMI	 correlates	 with	 VAT,	 we	 con-
ducted	 another	 meta-analysis	 without	 these	 two	 studies,	 which	
yielded	similar	results.	As	there	was	significant	heterogeneity	be-
tween studies (Q =	42.8,	p <	.001,	I2 =	74.3%),	we	followed	up	with	
moderator analyses.
3.2 | Moderation by gender
The	 effect	 sizes	 separate	 for	 gender	were	 not	 significantly	 differ-
ent (Q(1)	=	0.8,	p =	 .363).	In	females,	visceral	adipose	tissue	in	de-
pressed subjects was significantly larger than in healthy controls 
(SMD	=	0.44,	95%	CI	=	[0.17;	0.72],	p =	.002)	with	significant	hetero-
geneity (Q =	41.0,	p <	.001,	I2 =	78.0%).	Post-hoc	statistical	power	
was >99.99%.	In	males,	visceral	adipose	tissue	in	depressed	subjects	
was numerically larger but did not significantly differ from healthy 
controls	(SMD	=	0.16,	95%	CI	=	[−0.39;	0.71],	p =	.572)	without	sig-












p =	.160)	with	significant	heterogeneity	(Q =	11.9,	p =	.036,	I2 =	58.1%).	
Post-hoc statistical power was >99.99%	(see	Data	S2).
3.4 | Moderation by method of adipose tissue 
measurement
The	effect	sizes	separate	for	the	three	measurement	methods	were	
not significantly different (Q(2)	=	1.0,	p =	.594).	Visceral	adipose	tis-
sue in depressed subjects was numerically larger but did not signifi-
cantly	differ	when	measuring	via	CT	(SMD	=	0.21,	95%	CI	=	[−0.25;	
F I G U R E  2   Funnel plot of the studies 
on visceral adipose tissue in depressed 
versus non-depressed subjects
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0.67],	p =	 .370)	 and	when	measuring	 via	DXA	 (SMD	=	 0.33,	 95%	
CI =	[−0.14;	0.80],	p =	 .172)	with	evidence	of	significant	heteroge-
neity for CT (Q =	15.9,	p =	.001,	I2 =	81.2%)	and	for	DXA	(Q =	6.8,	
p =	.033,	I2 =	70.8%).	Post-hoc	statistical	power	for	CT	measurement	
was >99.99%,	 for	 DXA	 measurement	 65.07%.	 When	 measuring	
via MRT visceral adipose tissue in depressed subjects was signifi-
cantly	larger	than	in	healthy	controls	(SMD	=	0.52,	95%	CI	=	[0.13;	
0.90],	p =	.009)	without	significant	heterogeneity	(Q =	7.1,	p =	.132,	
I2 =	43.4%).	Post-hoc	statistical	power	was	>99.99%	(see	Data	S3).
3.5 | Moderation by method of 
depression assessment
The	 effect	 sizes	 separate	 for	 the	 two	methods	 for	 depression	 as-
sessment were not significantly different (Q(1)	 =	 0.9,	 p =	 .336).	
When	 depression	 was	 diagnosed	 by	 mental	 health	 professionals,	
visceral adipose tissue was significantly larger in depressed subjects 
than	in	healthy	controls	(SMD	0.42,	95%	CI	=	[0.16;	0.69],	p =	.002)	
with evidence of significant heterogeneity (Q =	 31.9,	 p <	 .001,	
I2 =	71.8%).	Post-hoc	statistical	power	was	99.98%.	When	depres-
sion	was	assessed	via	screening,	visceral	adipose	tissue	in	depressed	
subjects	 was	 numerically	 larger	 than	 in	 healthy	 controls,	 but	 this	
comparison	did	not	reach	significance	(SMD	=	0.17,	95%	CI	=	[−0.28;	
0.62],	p =	 .460)	with	 significant	heterogeneity	 (Q =	 4.4,	p =	 .035,	
I2 =	77.5%).	Post-hoc	statistical	power	was	90.61%	(see	Data	S4).
3.6 | Subcutaneous adipose tissue
Subcutaneous	 adipose	 tissue	was	 significantly	 larger	 in	 depressed	
subjects	than	in	healthy	controls	(SMD	=	0.26,	95%	CI	=	[0.09;	0.43],	






F I G U R E  3   Funnel plot of the studies 
on subcutaneous adipose tissue in 
depressed versus non-depressed subjects
F I G U R E  4  Visceral	adipose	tissue	in	depressed	versus	non-depressed	subjects.	CI,	confidence	interval;	Std	diff,	standardized	difference.	
Positive differences represent greater visceral adipose tissue in depressed subjects compared to non-depressed subjects








Examining	men	 and	women	 separately	 showed	 increased	 VAT	
in	 both	 sexes.	However,	 the	 results	were	 significant	with	 small	 to	
medium	effect	size	only	for	women	with	major	depressive	disorders	
or self-reported depressive symptoms compared to female healthy 
controls.	While	nine	studies	examined	652	women	with	major	de-
pressive	 disorder	 or	 self-reported	 depressive	 symptoms,	 only	 two	
studies reported data for men with major depressive disorder or 
self-reported depressive symptoms (n=280).	 Further	 research	 is	
necessary to particularly investigate the association between de-
pression in men and visceral adipose tissue.
When	 the	participants	were	divided	by	 the	mean	age,	 the	dif-
ferences between patients with major depressive disorder and 
self-reported depressive symptoms and the comparison group were 
numerically larger in the younger group as well as in the older group. 
However,	only	the	younger	group	displayed	a	significant	medium	ef-
fect	size.	This	may	suggest	that	patients	who	developed	depression	
earlier in life have a higher risk for increased visceral adipose tissue.
The pooled data showed that visceral adipose tissue between 
patients with major depressive disorder or self-reported depressive 
symptoms and healthy controls was numerically larger in all measure-
ment	methods:	DXA,	MRI	and	CT.	However,	only	MRI	measurement	
showed	a	significantly	medium	effect	size.	Remarkable,	studies	with	
MRI measurement may have less persons with comorbid anxiety 
spectrum	disorders,	e.g.	claustrophobia,	due	to	measurement	condi-
tions.	While	DXA	calculation	showed	 little	power,	we	may	failed	to	
see an effect. We found no significant results with CT measurements.
The differences between patients with major depressive dis-
order or self-reported depressive symptoms and healthy controls 
showed	significant	small	 to	medium	effect	sizes	when	the	diagno-
sis was examined by expert interviewers. When depression was 
assessed via self-rating scales there was still a small effect between 
patients with depressive symptom vs. healthy controls but it did not 
reach for statistical significance. Estimates of depression based on 
self-ratings typically yield depression prevalence estimates that are 
considerably higher than the estimates based on expert interviews. 
This means that studies based on self-rating may suffer from a high 
false	positive	rate	for	patients	classified	as	depressed.	Consequently,	
research should be based on reliable diagnoses.
Our findings are of considerable importance as abdominal obesity 
is the most prevalent manifestation of metabolic syndrome (Despres 
&	 Lemieux,	 2006),	 and	 both	 metabolic	 syndrome	 and	 depression	
are	highly	prevalent	in	the	general	population.	The	American	Heart	
Association	recommends	assigning	depression	as	a	risk	factor	for	ad-
verse medical outcomes in patients with acute coronary syndromes 
(Lichtman	et	al.,	2014).	An	altered	fat	distribution	could	be	a	possi-
ble link between depression and these effects. One of the studies 
included in our meta-analysis reported additional fat compartment 
measurements,	 i.e.,	 paracardial,	 pericardial	 and	 epicardial	 adipose	
tissue	 in	depressed	patients	and	controls	 (Kahl	et	al.,	2014,	2017).	
Pericardial adipose tissue was increased in patients with chronic 
major	depressive	disorder	compared	to	controls.	Because	there	was	
only	one	database,	we	could	not	use	these	data	in	our	meta-analysis.	
For	 future	 research,	 the	measurement	 of	 these	 fat	 compartments	
as a potential contributing link between depression and cardiac dis-
eases	represents	a	promising	approach.	None	of	the	included	studies	
recorded	any	effects	of	antidepressant	medication	on	VAT.	Because	
drug	 intake	was	 differently	 registered	 and	 summarized	 in	 primary	
studies we were not able to take antidepressant medication as a 
moderator in our meta-analysis.
Due to inclusion criteria and study design two other studies in 
this	 field	 could	not	be	 included.	However,	 they	are	 in	our	opinion	
worth	to	mention:	Everson-Rose	et	al.	(2009)	published	a	correlative	
study with 409 women examined for depressivity and intra-abdomi-
nal adipose tissue using CT. Depressed women showed significantly 
higher	 adipose	 tissue	 in	 the	 intra-abdominal	 areas.	 Lasserre	 et	 al.	
(2014)	 used	 subtypes	 of	 depression	 to	 investigate	 whether	 these	
subtypes are predictive for adiposity and changes in body composi-
tion. They found that participants with the atypical subtype of MDD 
F I G U R E  5  Subcutaneous	adipose	tissue	in	depressed	versus	non-depressed	subjects.	CI,	confidence	interval;	Std	diff,	standardized	
difference. Positive differences represent greater subcutaneous adipose tissue in depressed subjects compared to non-depressed subjects
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had greater increases in adiposity than participants without MDD; 
however,	VAT	was	not	measured.
When	 evaluating	 possible	 moderators,	 we	 must	 consider	 that	




gression analysis with a high number of covariates. It remains unclear 
whether	or	to	what	extent	behavioral	and	individual	factors,	i.e.,	the	
use	 of	medication,	 eating	 behavior,	movement	 behavior,	 abuse	 of	
substances,	somatic	and	psychiatric	comorbidities	or	duration	of	ill-
ness,	contribute	to	the	amount	of	VAT.
There are several hypotheses about how depressive symptoms 
might contribute to higher visceral adiposity—a dysregulation of the 
hypothalamic-pituitary-adrenocortical	(HPA)	system,	a	developmen-
tal	origin	of	health	and	disease,	and	adipose	tissues	as	an	endocrine	
organ.	First,	 it	 is	postulated	that	 the	development	of	depression	 is	
connected with dysregulation of mineralocorticoid receptors and 
glucocorticoid	receptors.	Both	of	these	receptors	are	part	of	the	HPA	
system	(Holsboer,	2000;	Young	et	al.,	2003).	For	example,	patients	
with major depression with psychosis have higher evening cortisol 
levels than patients with major depression without psychosis and 
healthy	controls	(Keller	et	al.,	2017).	A	higher	severity	of	hypercorti-
solism	was	correlated	with	higher	visceral	adiposity	(Delivanis	et	al.,	





of the developmental origins of health and disease may be relevant. 
The child of a mother experiencing stress during pregnancy has an in-
creased	risk	of	an	altered	functioning	of	the	HPA	axis	(Glover,	2011).	





tissue is considered one of the largest endocrine organs in the body. 
Adipose	 tissue	 is	able	 to	 synthesize	and	 release	a	 large	number	of	
metabolic products. Excessive visceral fat accumulation causes ad-






strated	 in	 patients	with	 depression	 (Shafiee	 et	 al.,	 2018).	 There	 is	
evidence that genetic variants that increase immune responses are 
more	frequent	in	patients	with	depression	or	characterize	a	group	of	
individuals at increased risk of developing a depressive phenotype. 
Concurrently,	there	is	some	evidence	that	increased	inflammation	is	
present in a subgroup of depressed patients who were exposed to 
stress	early	in	childhood	or	even	in	utero	(Pariante,	2017).	Of	course,	
these putative mechanisms are not mutually exclusive and may well 
work in parallel.
4.1 | Strengths & limitations
This meta-analysis was able to identify a substantial number of pub-
lications. We found no evidence for publication bias using the funnel 
plot	technique	(see	Figures	2	and	3).	The	main	limitation	was	the	fact	
that	most	 of	 the	 included	 studies	were	 pilot	 studies.	 A	methodo-
logical limitation comes from some studies including chronically de-
pressed participants and some studies including participants whose 
depressive symptoms had lasted only for a short interval prior to 
measurement.	 Furthermore,	 there	 was	 a	 lack	 of	 longitudinal	 data	
that could enable us to draw further conclusions. Meta-analysis for 
other adipose tissue compartments could not be carried out due to 
lack of studies measuring them. Further research is needed to exam-
ine in which way and to what extent depressive symptoms contrib-
ute to visceral adiposity.
5  | CONCLUSION
In	this	meta-analysis,	depression	was	associated	with	enlarged	vis-




subcutaneous adipose tissue was enlarged in patients with depres-
sion.	Further,	especially	longitudinal,	research	is	needed	to	identify	
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